JAY T FLATLEY
CIK 1189130 · Chairman and Acting CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$35.34M
Companies
6
Total Filings
353
Lifetime Open-Market Net
-$491.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNLI | Director | 358,941 | $21.66 | $7.77M | $0 | 12 | 2026-06-05 |
| RIVN | Director | 160,820 | $16.76 | $2.70M | $2.75M | 7 | 2026-03-05 |
| Zymergen Inc. (ZY) Delisted | Chairman and Acting CEO | 0 | $2.43 | $0 | $1.00M | 4 | 2022-10-19 |
| COHR | Director | 856 | $385.03 | $329.6K | -$2.07M | 22 | 2022-07-01 |
| ILMN | Director | 152,433 | $160.97 | $24.54M | -$494.38M | 303 | 2021-05-20 |
| Juno Therapeutics, Inc. (JUNO) Delisted | Director | 0 | — | — | $724.4K | 5 | 2018-03-07 |
Recent Filings · Page 9 of 36
353 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-07 | ILMN | Tax (F) | −2,337 | -$757.5K | EDGAR |
| 2018-10-26 | ILMN | Sell (S) | −3,300 | -$1.02M | EDGAR |
| 2018-10-12 | ILMN | Sell (S) | −3,300 | -$1.06M | EDGAR |
| 2018-09-28 | ILMN | Sell (S) | −3,300 | -$1.19M | EDGAR |
| 2018-09-14 | ILMN | Sell (S) | −3,300 | -$1.16M | EDGAR |
| 2018-06-15 | DNLI | Grant (A) | — | $0 | EDGAR |
| 2018-05-16 | ILMN | Sell (S) | −1,460 | -$391.3K | EDGAR |
| 2018-03-07 | Juno Therapeutics, Inc. (JUNO) Delisted | Mixed | −31,500 | -$2.74M | EDGAR |
| 2018-03-05 | COHR | Grant (A) | +916 | $0 | EDGAR |
| 2018-02-20 | ILMN | Mixed | +13,660 | -$2.95M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.